CL
DIAX

Choreo LLC’s Nuveen Dow 30SM Dynamic Overwrite Fund DIAX Stock Holding History

Choreo LLC’s Portfolio DIAX Stock Details DIAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-36,354
Closed -$565K – 1635
2025
Q4 		$565K Sell
36,354
-1,334
-4% -$19.8K 0.01% 868
2025
Q3 		$573K Sell
37,688
-1,174
-3% -$17K 0.01% 865
2025
Q2 		$569K Sell
38,862
-1,272
-3% -$17.7K 0.01% 832
2025
Q1 		$594K Sell
40,134
-378
-0.9% -$5.69K 0.01% 750
2024
Q4 		$612K Buy
40,512
+5,561
+16% +$84.3K 0.01% 797
2024
Q3 		$518K Buy
34,951
+4,482
+15% +$64.3K 0.01% 885
2024
Q2 		$427K Buy
+30,469
New +$427K 0.01% 889

Other funds holding DIAX

SC
Stolper & Co Tulsa, Oklahoma $387M AUM 25.53% 1-Year Est. Return
FAM
Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return
PTC
Private Trust Company Cleveland, Ohio $1.25B AUM 29.12% 1-Year Est. Return

Choreo LLC's DIAX Position: Q1 2026 in Review

Choreo LLC sold out of Nuveen Dow 30SM Dynamic Overwrite Fund (DIAX) in Q1 2026, closing a stake of 36,354 shares — an estimated $565K sold.

Choreo LLC first reported a position in DIAX in Q2 2024 and held it in 7 quarters. The position peaked at $612K in Q4 2024. 3 funds tracked by Wall St. Rank hold DIAX as of Q1 2026.

  • Choreo LLC reported no remaining Nuveen Dow 30SM Dynamic Overwrite Fund position as of Q1 2026 after selling out during the quarter.
  • Choreo LLC sold 36,354 Nuveen Dow 30SM Dynamic Overwrite Fund shares in Q1 2026, an estimated $565K.
  • Choreo LLC first reported a position in Nuveen Dow 30SM Dynamic Overwrite Fund in Q2 2024 and held it in 7 quarters.
  • Choreo LLC's Nuveen Dow 30SM Dynamic Overwrite Fund position peaked at $612K in Q4 2024.
  • 3 funds tracked by Wall St. Rank held Nuveen Dow 30SM Dynamic Overwrite Fund as of Q1 2026.

Based on Choreo LLC's 13F filing for Q1 2026, filed 13 May 2026.